Question 1

What specific benefits might I expect from ALKS 5461 compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) clinical trial (NCT03610048). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of ALKS 5461?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) clinical trial (NCT03610048). Contact the study team or your healthcare provider for specific answers.

Question 3

How often would I need to visit the clinic during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) clinical trial (NCT03610048). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) clinical trial (NCT03610048). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any other treatment options I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) clinical trial (NCT03610048). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) clinical trial (NCT03610048). Contact the study team or your healthcare provider for specific answers.

What this study is about